Zydus Pharmaceuticals USA recalls

Zydus Pharmaceuticals USA has 41 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 19 Feb 2020. The most frequent reason is manufacturing (cgmp) deviations.

Total recalls41since 2012
Last 12 months0reported
Class I12% of total
Ongoing0latest 19 Feb 2020

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 2%Class II 34 83%Class III 6 15%

Why zydus pharmaceuticals usa is recalled

By year

All zydus pharmaceuticals usa recalls, newest first

41 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIEthacrynate Sodium for Injection, USP, 50mg/vial, Single Dose Vial recalledZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIPramipexole Dihydrochloride Tablets 1 mg recalledZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethylPREDNISolone Tablets, USP 32 mg recalledMethylprednisoloneZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIPramipexole Dihydrochloride Tablets 0.25 mg recalledZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIPramipexole Dihydrochloride Tablets 0.125 mg recalledZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIAnastrozole Tablets, 1 mg recalled by Zydus Pharmaceuticals USAAnastrozoleZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIPramipexole Dihydrochloride Tablets 1.5 mg recalledZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIPramipexole DihydrochlorideTablets 0.125 mg recalledZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethylPREDNISolone Tablets, USP dosepack recalledMethylprednisoloneZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIPramipexole Dihydrochoride Tablets 0.25 mg recalledZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethylPREDNISolone Tablets, USP 16 mg recalledMethylprednisoloneZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethylPREDNISolone Tablets, USP 8 mg recalledMethylprednisoloneZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIAnastrozole Tablets, USP, 1 mg recalled by Zydus Pharmaceuticals USAAnastrozoleZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIPramipexole Dihydrochloride Tablets 0.5 mg recalledZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethylPREDNISolone Tablets, USP, 4 mg recalledMethylprednisoloneZydus Pharmaceuticals USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IICarvedilol Tablets, USP, 6.25 mg recalled by Zydus Pharmaceuticals USACarvedilolZydus Pharmaceuticals USAPackaging DefectsNationwide
DrugCLASS IIAcyclovir Tablets, USP, 400 mg recalled by Zydus Pharmaceuticals USAAcyclovirZydus Pharmaceuticals USAPackaging DefectsNationwide
DrugCLASS IIICarvedilol Tablets, USP, 3.125 mg recalled by Zydus Pharmaceuticals USACarvedilolZydus Pharmaceuticals USAOtherNationwide
DrugCLASS IIParoxetine Tablets USP, 30 mg, a) recalled by Zydus Pharmaceuticals USAParoxetineZydus Pharmaceuticals USAOtherNationwide
DrugCLASS IIParoxetine tablets USP, 30mg recalled by Zydus Pharmaceuticals USAParoxetineZydus Pharmaceuticals USAOtherNationwide
DrugCLASS IIDivalproex Sodium Delayed Release Tablets, USP, 500 mg, a.) bottle recalledZydus Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIDivalproex Sodium Delayed Release Tablets, USP, 125 mg recalledZydus Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIDivalproex Sodium Delayed Release Tablets, USP, 250 mg bottle recalledZydus Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIDivalproex Sodium Delayed Release Tablets, USP, 500 mg, a) recalledZydus Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIAtenolol Tablets, USP, 50 mg recalled by Zydus Pharmaceuticals USAAtenololZydus Pharmaceuticals USAPackaging DefectsNationwide
DrugCLASS IIIBuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg recalledBupropionZydus Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIIBuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg recalledBupropionZydus Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIBromocriptine Mesylate Capsules USP, 5 mg recalledBromocriptine MesylateZydus Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIVenlafaxine HCL ER Capsule USP, 75mg recalledVenlafaxine HydrochlorideZydus Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIVenlafaxine HCL ER Capsule USP, 150mg recalledVenlafaxine HydrochlorideZydus Pharmaceuticals USAPotency & AssayNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.